Mutations in Centrosomal Protein CEP152 in Primary Microcephaly Families Linked to MCPH4  by Guernsey, Duane L. et al.
ARTICLE
Mutations in Centrosomal Protein CEP152
in Primary Microcephaly Families Linked to MCPH4
Duane L. Guernsey,1,3 Haiyan Jiang,1 Julie Hussin,5 Marc Arnold,7 Khalil Bouyakdan,5 Scott Perry,1
Tina Babineau-Sturk,2 Jill Beis,2 Nadine Dumas,2 Susan C. Evans,1 Meghan Ferguson,2
Makoto Matsuoka,1 Christine Macgillivray,1 Mathew Nightingale,1 Lysanne Patry,5 Andrea L. Rideout,2
Aidan Thomas,2 Andrew Orr,3 Ingrid Hoffmann,7 Jacques L. Michaud,5 Philip Awadalla,5
David C. Meek,6 Mark Ludman,2,4 and Mark E. Samuels1,5,*
Primary microcephaly is a rare condition in which brain size is substantially diminished without other syndromic abnormalities. Seven
autosomal loci have been genetically mapped, and the underlying causal genes have been identiﬁed for MCPH1, MCPH3, MCPH5,
MCPH6, andMCPH7 but not for MCPH2 orMCPH4. The known genes play roles inmitosis and cell division.We ascertained three fami-
lies from an Eastern Canadian subpopulation, each with onemicrocephalic child. Homozygosity analysis in two families using genome-
wide dense SNP genotyping supported linkage to the published MCPH4 locus on chromosome 15q21.1. Sequencing of coding exons of
candidate genes in the interval identiﬁed a nonconservative amino acid change in a highly conserved residue of the centrosomal protein
CEP152. The affected children in these two families were both homozygous for this missense variant. The third affected child was
compound heterozygous for the missense mutation plus a second, premature-termination mutation truncating a third of the protein
and preventing its localization to centrosomes in transfected cells. CEP152 is the putative mammalian ortholog of Drosphila asterless,
mutations in which affect mitosis in the ﬂy. Published data from zebraﬁsh are also consistent with a role of CEP152 in centrosome func-
tion. By RT-PCR, CEP152 is expressed in the embryonic mouse brain, similar to other MCPH genes. Like some other MCPH genes,
CEP152 shows signatures of positive selection in the human lineage. CEP152 is a strong candidate for the causal gene underlying
MCPH4 and may be an important gene in the evolution of human brain size.Introduction
Primary microcephaly (PM) is deﬁned by a head circumfer-
ence more than three standard deviations below the age-
and sex-adjusted mean. The reduced head size appears to
be directly caused by smaller brain size, without speciﬁc
structural brain abnormalities, beginning prenatally and
continuing through childhood. PM may be of sporadic or
familial etiology. Seven different chromosomal loci for
this trait have been genetically mapped, named appropri-
ately as MCPH1–MCPH7 (MIM 251200, 604317, 604804,
604321, 608716, 608393, and 612703, respectively). The
causal genes have been identiﬁed for loci MCPH1,
MCPH3, MCPH5, MCPH6, and MCPH7 (genes MCPH1
[MIM 607117], CDK5RAP2 [MIM 608201], ASPM [MIM
605481], CENPJ [MIM 609279], and STIL [MIM 181590],
respectively), but not for MCPH2 or MCPH4 until now.1–6
Unlike syndromic forms of microcephaly, patients with
PM do not have any other obvious organ or morphological
problems. The known genes play roles in cell division,
particularly in chromosome segregation and centrosome
function, and some have been directly shown to be
expressed in rapidly dividing cells in mouse embryonic
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evolution, as several studies document evidence of positive
selection in the primate lineages.7–11 In this report, we
document pathogenic mutations in a centrosomal protein
within the published MCPH4 chromosomal region, in
three patients with PM.Subjects and Methods
Clinical Ascertainment and Consent
Patients were identiﬁed in the course of routine clinical ascertain-
ment and treatment of developmental and behavioral disorders in
the child neurology traveling clinics of New Brunswick, Canada.
Approval for the research study was obtained from the research
ethics board of the IWK Health Centre in Halifax, Nova Scotia,
Canada. All sampled family members provided informed consent
to participate in the study. DNA was obtained from blood samples
via routine extraction methods.Genotyping and Analysis
Whole-genome SNP scanning was performed at the McGill
University and Genome Quebec Centre for Innovation, with the
use of the Illumina Human610-Quadv1_B panel. Data were
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BeadLab software, on the Inﬁnium II FastScan setting. Allele calls
were generated with Beadstudio version 3.1, with the Genotyping
Module used. Regions of homozygosity shared identically by state
(IBS) in the two genotyped affected patients were determined by
direct inspection with the use of customized scripts.Mutation Detection and Bioinformatic Analysis
Annotated coding exons were ampliﬁed from patient genomic
DNA by PCR via standardmethods and were sequenced at Dalhou-
sie University, via Sanger ﬂuorescent sequencing and capillary
electrophoresis. Control samples were sequenced at the McGill
University and Genome Quebec Centre for Innovation Sequence.
Traces were analyzed with MutationSurveyor (Soft Genetics).
Homologous protein sequences of the human CEP152 gene
were retrieved from NCBI genome database with BLASTP. Only
the genes annotated as centrosomal protein 152kDa (CEP152) or
predicted protein similar to CEP152 were selected as the orthologs
of human CEP152. Multiple sequence alignments (MSAs) were
generated with MUSCLE.12 The effect of amino acid substitution
on protein function was predicted with SIFT,13–15 PolyPhen,16–18
PANTHER,19,20 and Align-GVGD.21,22 Protein sequence of the
human CEP152 gene was used as the input for SIFT, PolyPhen,
and PANTHER. Default query options were used for SIFT and Poly-
Phen prediction.MSA of the CEP152 protein orthologs was used as
the input MSA for Align-GVGD.
To study conserved domains in CEP152, reference sequence
(NP_055800.2) was used as a query in the NCBI CD-Search tool
with parameters Database ¼ CDD,Maximal_hits ¼ 250, Expect_va-
lue_threshold ¼ 0.0001, and Apply_low_complexity_ﬁlter ¼ yes.23
The CEP152 reference protein sequence and mutant CEP152
sequence were analyzed via several coiled-coil prediction
methods: COILS, Paircoil2, and Marcoil.24–27 The following
parameters were used in the analyses: COILS window_width ¼ 28,
matrix ¼ MTIDK, weighting ¼ yes; Paircoil2 p-score_cutoff ¼ 0.025,
minimum_search_window_length ¼ 28; Marcoil cc_emission_
prob_matrix ¼ { 9FAM, MTIDK, MTK }, HMM_prob_matrix ¼
MARCOIL-H. SOSUIcoil was also used to predict putative coiled-
coil fragile points in both the reference and mutant protein
sequences.28Mouse Work
RT-PCR was performed with the use of RNA extracted from embry-
onic day 12.5 or 14.5 mouse brain via standard methods. The or-
thologous mouse Cep152 gene was ampliﬁed from cDNA with
the use of the following PCR primers: forward, 50-GCTGTCAC
TCGCACTCTCTG-30 (in mouse exon 21, per NM_001081091);
reverse, 50-CACCCTGCTGTTCTCCTCTC-30 (in mouse exon 24).
In situ hybridization to embryonic mouse brain sections was per-
formed as described.29 The procedures followed were in accor-
dance with the ethical standards of the responsible committee
on animal experimentation.Functional Studies in Cells
Full-length human CEP152 cDNA corresponding to reference
sequence NM_014985 was cloned between the KpnI and XhoI
sites of pEGFP-c1 (Clontech). Mutations corresponding to those
observed in the human microcephaly patients were introduced
with the QuikChange Lightning Site-Directed Mutagenesis Kit
(Stratagene) according to the manufacturer’s protocol. All
constructs were veriﬁed by sequencing.ThHuman osteosarcomas-derived U2OS cells were transfected with
the wild-type or the two different mutant fusions to green ﬂuores-
cent protein (GFP). Cells were ﬁxed with ice-cold methanol for
10 min at 20C. They were washed with PBS and blocked with
2% BSA in PBS for 30 min. Cells were incubated with mouse-
anti-g(gamma)-tubulin for 1 hr and with secondary antibody for
30 min, respectively. DNA was stained with Hoechst. Between
each step, cells were washed three times with 2% BSA in PBS. All
incubations took place at room temperature. Images were taken
with a PerkinElmer Ultra-View spinning-disc confocal system on
a Nikon Ti inverted microscope. Mouse-anti-g-tublin (GTU-88)
was purchased from Sigma-Aldrich.Molecular Evolution Analysis
Sequences were aligned via the method incorporated in the soft-
ware RevTrans.30 This program generates multiple alignment of
coding DNA sequences from aligned amino acid sequences, ob-
tained in this study from NCBI: Homo sapiens centrosomal protein
152 (GI: 110347567:35-4999), Pan troglodytes centrosomal protein
152 (GI: 114656898:194-5326), Mus musculus centrosomal
protein 152 (GI: 124487355:246-5456), Rattus norvegicus centroso-
mal protein 152 (GI: 109468754jrefjXM_230555.4), Monodelphis
domestica similar to CEP152 protein (GI: 126278234jrefj
XM_001380412.1), and Gallus gallus similar to rai-like protein
(GI: 118095786:1-5310). The tree was computed with PhyML.31
Genomic sequences of other primates were obtained by manual
alignment and inspection of the human gene with the primate
genomic consensus sequences, and extraction and predicted trans-
lation of all coding exons. This was possible for chimpanzee,
orangutan, rhesus, and marmoset, but not for other primate
genomes, including gorilla and bonobo, which contain gaps pre-
venting the identiﬁcation of all orthologous coding-exon
sequences (see Figure S7, available online, for all predicted protein
sequences).
For estimation of nonsynonymous/synonymous substitution
ratios, u (¼ Ka/Ks ¼ dN/dS), the method implemented in PAML,
was used.32 First, u values were calculated with the branch models
implemented in PAML, in which u is allowed to vary among all
branches in the tree. With branch-site models, u values are allowed
to vary among branches and codons, for the detection of sites tar-
geted by positive selection in speciﬁc lineages or all lineages.33Results
Clinical Description
In the course of clinical work, we ascertained three families
from a rural Maritime Canadian subpopulation, each with
one child presenting with PM. In all families, both parents
were of Acadian descent. None of the parents were known
to be consanguineous, and none had any other children
after the birth of the child with microcephaly (see Figures
1A–1C for pedigrees, Figure 1D for photograph of one
patient, and Figures 1E and 1F for MRI scans of one
patient).
The patients had microcephaly, with head circumfer-
ence between ﬁve and seven standard deviations below
the mean (see Figures 2A and 2B for head growth charts).
There were no other dysmorphic signs, and height and
weight were normal. They were noted to be very visuallye American Journal of Human Genetics 87, 40–51, July 9, 2010 41
Figure 1. MaritimeMicrocephaly Cohort
(A–C) Maritime families 1–3 of patients
carrying mutations in the CEP152 gene.
Affected probands are represented by fully
shaded symbols, noted by arrowheads.
(D) Photograph of microcephalic patient
1937 (with mother).
(E and F) MRI scans of the head of patient
1937 at the age of 18 yrs.attentive and to have fast, rather jerky movements in
infancy. They all had prominent mirror movements that
persisted into childhood. From an early age, they were
very happy and friendly and seemed very aware socially.
The patients walked alone between 14 and 15 mo of age,
two of them toe walking at ﬁrst. They were talking to
express themselves by 3 yrs of age. All three children
learned to read and attended regular classes with some
modiﬁcation. One patient (1937) had psychological
testing, including the WISC-IV, which showed moderate
cognitive impairment, with both verbal and performance
scores below the 1st percentile but with visual motor skills
up to the 4th percentile. One girl (1669) excelled at reading
and kept up to her peers academically until the age of 11
yrs. They all responded strikingly quickly to social or verbal
cues, but at times they exhibited challenging behavior,
being impulsive and aggressive and having tantrums.
One (1672) had tics. Another (1937) had obsessive and/
or compulsive traits. She was self-conscious about her42 The American Journal of Human Genetics 87, 40–51, July 9, 2010small head size and invented other
reasons for her appointments: ‘‘I’ve
got a broken leg’’ or ‘‘I’m very sick
with asthma.’’ She acted these parts
remarkably well, with pained expres-
sion and limping gait or rapid
breathing. The three children were
otherwise healthy at their last
follow-up visit, at the ages of 10–18
yrs. None had epilepsy.
An MRI scan was performed for one
patient (1937), showing markedly
reduced brain size with mild enlarge-
ment of the posterior horns of the
lateral ventricles. The gyral pattern
was simpliﬁed, in keeping with the
small brain size, but the cortex ap-
peared of normal thickness. The pitui-
tary gland appeared large in compar-
ison to thebrainbutwasofnormal size.
Molecular Mapping and Mutation
Detection
Initially we were able to sample two
of the affected patients (1669 and
1672) and their parents. We per-
formed high-density genome-wide
SNP genotyping, using the Illuminapanel of 610,000 markers, and looked for regions of
extended homozygosity shared IBS in the two affected
individuals but not in their parents. As shown in Table 1,
among the ten longest series of consistent SNPs, a 14
Mbp region on chromosome 15q21.1 appeared as a clear
outlier, both by physical length and by number of consec-
utive homozygous IBS-shared SNPs. Parents of the affected
children were heterozygous for many SNPs in the region,
indicating that the markers were genetically informative
(data not shown). The region was broken into three subsec-
tions, each separated by a single SNP, which we infer to
represent false heterozygous genotype calls. The combined
interval, from approximately 39–53 Mbp (February 2009
Human Genome Assembly hg19), lies within the larger
published MCPH4 locus, which is deﬁned by an anony-
mous marker near D15S1042 and by D15S98, equivalent
to 36–60 Mbp in hg19.34 Two additional families have
also been reported as linked to MCPH4, but without any
further localization information.35 In our two genotyped
Figure 2. Growth Charts Tracking the
Head Circumference of OurMicrocephalic
Patients from an Early Age Compared to
Population Means for Girls and Boys
Solid lines show the mean head size at
various ages. Dashed lines show the limits
of two standard deviations above or below
the mean size.
(A) Females: x represents patient 1669,
dotted circle represents patient 1937.
(B) Males: x represents patient 1672.patients, there was no evidence of homozygosity at any of
the ﬁve known microcephaly genes—MCPH1, CDK5RAP2,
ASPM, CENPJ, and STIL—or at the remaining MCPH2
locus. We also sequenced these ﬁve genes (total 112 coding
exons) in our affected patients, without ﬁnding any poten-
tially pathogenic variants.The American Journal of HThe region deﬁned by our patients
includes more than 150 RefSeq anno-
tated genes. On the basis of the
known or hypothesized functions of
the characterized gene products of
MCPH1, MCPH3, MCPH5, MCPH6,
and MCPH7, we prioritized genes
likely to have functions related to
cell division or chromosomal segrega-
tion. In all, we sequenced 261 coding
exons of 14 genes (TMOD2 [MIM
602928], TP53BP1 [MIM 605230],
MAP1A [MIM 600178], HAUS2,
TUBGCP4 [MIM 609610], NUSAP1
[MIM 612818], BUB1B [MIM
602860], MFAP1 [MIM 600215],
USP8 [MIM 603158], MYO5A [MIM
160777], STARD9, GABPB1 [MIM
600610], RAD51 [MIM 179617], and
CEP152), until we observed an inter-
esting missense variant in the gene
CEP152. As shown in Figure 3A,
this is a glutamine-to-proline change
at residue 265 of the protein
(p.Q265P), found to be homozygous
in samples from the two affected
patients, 1669 and 1672, and hetero-
zygous as expected in the four parents
(data not shown). This amino acid
variant is not present in dbSNP build
130, nor was it detected in any of
310 local Maritime control chromo-
somes or 186 European control chro-
mosomes from the Centre d’Etude du
Polymorphisme Humain (CEPH). No
other homozygous coding variants
were detected by sequencing this set
of candidate genes in the two affected
patients.Subsequently, we were able to sample the remaining
family. The third patient (1937) was likewise negative for
mutations in the ﬁve known MCPH genes. Unexpectedly,
the third affected patient was heterozygous only for the
p.Q265P missense variant, as was only one parent. Rese-
quencing of all the remaining CEP152 coding exons inuman Genetics 87, 40–51, July 9, 2010 43
Table 1. Twelve Longest Intervals of Consecutive SNPs Homozygous and Identical by State in the Two Genotyped Affected Microcephaly
Patients
nSNPs Chr. BeginSNP EndSNP Begin End Size
1158 15 rs768269 rs16953764 37 022 649 44 400 816 7 378 168
621 15 rs16953764 rs11634375 44 400 816 47 536 840 3 136 025
602 15 rs11634375 rs2017176 47 536 840 50 793 439 3 256 600
173 5 rs11743309 rs27466 45 158 145 50 125 676 4 967 532
129 6 rs4713119 rs12661831 27 820 804 28 445 748 624 945
120 4 rs6531772 rs6849320 33 432 805 34 441 990 1 009 186
105 12 rs1265566 rs6489848 110 200 759 111 457 037 1 256 279
85 3 rs12631750 rs11925493 131 536 341 131 994 964 458 624
83 4 rs9714696 rs4697693 9 094 398 9 504 958 410 561
80 9 rs2564362 rs10760302 125 325 467 125 762 468 437 002
74 17 rs4793119 rs9908256 39 979 930 40 406 871 426 942
73 18 rs12457620 rs9948246 64 152 547 64 252 757 100 211
Intervals are in descending order of number of consecutive SNPs, with the presumptive linked interval on chromosome 15 italicized and bolded. Columns give the
number of consecutive homozygous SNPs identical by state, the chromosome, the first heterozygous SNP before the homozygous interval, the first heterozygous
SNP after the homozygous interval, the nucleotide position of the first heterozygous SNP before, the nucleotide position of the first heterozygous SNP after, and
the size of the interval spanned from the first heterozygous SNPs (none of these regions spans a centromere). Nucleotide positions are based on human genome
assembly hg18.this patient identiﬁed a second mutation, a stop codon at
residue arginine 987, p.R987X, caused by a CGA-to-TGA
change (Figure 3B). This mutation was heterozygous in
the other parent, consistent with independent segregation
of the two mutations in this presumably compound-
heterozygous patient, and was not detected in either the
local controls or the CEPH controls. This mutation would
cause an obligate protein truncation eliminating 668
C-terminal amino acids of the protein. Given the sequenc-
ing results, neither the third patient nor the parents were
genotyped across the entire genome.Bioinformatic Mutation Analysis
Residue 265 is highly conserved among vertebrates
(Figure 4A, Figure S1). The p.Q265P mutation is predicted
to be pathogenic by SIFT and Polyphen (Table S1).
PANTHER failed to give a prediction. The mutation was
predicted as benign by Align-GVGD with the use of the
MSA including theD. rerio sequence (which is signiﬁcantly
divergent from the other vertebrate orthologs), but delete-
rious if theDanio sequence was omitted. Residue 265 in the
human gene lies in a conserved SMC_prok_B domain
found in proteins that play a role in organizing chromo-
somes for cell division (hence, Structural Maintenance of
Chromosomes) (Figure 4B, Figure S2, Table S2). More
speciﬁcally, residue 265 is predicted to fall in a coiled-
coiled region according to COILS, Paircoil2, Marcoil, and
SOSUIcoil (Figure 4C, Figures S3 and S4). COILS, Paircoil2,
and Marcoil (with the use of the MTK emission matrix) all
predict that the mutant proline residue would weaken
the coiled-coil structure (Figures S3 and S4, Tables S3–S5).
SOSUIcoil predicts that residue 265 itself is a weak coiled-44 The American Journal of Human Genetics 87, 40–51, July 9, 2010coil residue in both the wild-type and mutant sequences
(Figure S5). The identiﬁcation of two different pathogenic
mutations in CEP152 makes it a strong candidate for the
causal gene in our patients and the presumptive gene
underlying MCPH4 generally.
Functional Studies on CEP152
Expression of some microcephaly genes can be detected in
dividing cells of mouse embryonic brain, particularly in
the ventricular zone.7,36–38 We were able to generate
a cDNA clone product of the correct size spanning exons
21–24 of the mouse Cep152 ortholog by using RNA
extracted from mouse brain tissue; cDNA could be readily
detected in stage 12.5 and 14.5 embryonic brains (Figure 5).
By in situ hybridization with two different probes, no
signal could be observed above background, suggesting
a low level of Cep152 expression in those tissues.
We tested for functional effects of the two mutations by
transfecting human U2OS osteosarcoma-derived cells
with wild-type or mutant human CEP152 fused to GFP.
Transfected GFP alone was not detectable in centrosomes,
marked by costaining with antibody to g-tubulin (Figure 6,
top row), whereas wild-type CEP152-GFP was detected in
centrosomes (Figure 6, middle row). The truncated
CEP152 p.R987X-GFP protein was not detected in centro-
somes (Figure 6, lower row). The point mutant CEP152
p.Q265P-GFP could be detected in centrosomes (data not
shown).
Molecular Evolution Studies
Molecular evolution studies of other microcephaly genes
have suggested that some of these are under positive
selection in primates. We asked whether CEP152 has been
subject to adaptive changes in humans. We used models
allowing different levels of heterogeneity in the nonsy-
nonymous/synonymous substitution ratio u ¼ Ka/Ks.
Ratio estimates of u greater than 1 indicate an excess of
amino acid changes relative to the silent or neutral expec-
tation and suggest adaptive evolution. Estimates of u less
than 1 are suggestive of selective constraints. Our analysis
is similar to that employed in an evolutionary study of the
microcephaly gene ASPM.39
By comparison of the human gene with other primate
and vertebrate orthologs, we found an elevated value
(greater than 1) of u ¼ 1.43 only in the human branch
(Figure 7A), signiﬁcantly different from the other ratios
throughout the tree, consistent with positive (adaptive)
selection in this gene speciﬁc to that lineage (p ¼
1.23 3 102, by comparing models B and D in Figure 7B).
By detailed comparison across the coding region of
CEP152 among vertebrate sequences, some segments are
demonstrably more conserved than others (Figure S6).
To incorporate this into selection models, we allowed u
ratios to vary both across lineages and among sites in
the protein. This provides greater resolution, because sites
of potential positive or negative selection may be inter-
spersed with domains undergoing only neutral variation.
The increased resolution is at the expense of power,
because the number of available sites is decreased by
testing subdomains rather than the entire protein. None-
theless, we detected the presence of sites subject to adap-
tive evolution in the human branch (H) (p ¼ 1.23 3 102).
Speciﬁcally eight sites in the protein are potentially under
positive selection (Figure 7C).Discussion
By homozygosity mapping in patients from an Eastern
Canadian subpopulation affected with PM, we identiﬁed
two independent rare mutations in the gene encoding
CEP152. Our three affected patients were either homozy-
gous or compound heterozygous for these mutations. One
mutation is a nonconservative change of glutamine to
proline at a highly conserved residue and is predicted to
be pathogenic, disturbing a potential coiled-coil domain
of the protein. The second mutation is an obligate protein
truncation removing a large C-terminal proportion of the
predicted coding region. In comparing the phenotypes of
the two females, the compound heterozygous individual
1937 showed greater reduction in expected head size than
themissense homozygous individual 1669. The truncating
allelemay thus bemore severe than themissense, although
this must be considered tentative, given that there were
only two affected individuals to compare. The truncation
could conceivably cause nonsense-mediated decay of the
mutated transcript; however, fresh tissue from the
compound-heterozygous patient was not available for
testing of this directly. In a functional assay for subcellularThlocalization, the wild-type CEP152-GFP fusion protein
could be detected in structures costaining for g-tubulin.
These are either centrioles or centrosomes (or both), given
that the tubulin antibody does not allow a formal distinc-
tion between these two related structures. Using a new anti-
body speciﬁc forCEP152N-terminal sequence,wehave also
detected the protein in bona ﬁde centrioles in untrans-
formed serum-starved hTERT-RPE cells (M.A., unpublished
data). The mutant CEP152 protein fusing the equivalent
truncated human protein to GFP failed to colocalize with
g-tubulin, verifying pathogenicity of the mutation. Locali-
zation is only apartial assay for the functional geneproduct.
It was not possible to assess full functionality of themutant
CEP152 proteins in the absence of the endogenously
expressed gene; thus, the p.Q265P missense mutation
may have amore subtle effect on cell division despite being
physically present in the centrosome in the qualitative
immunohistochemical assay. Expression of the CEP152
gene could be detected by RT-PCR in embryonic mouse
brains.
Our molecular evolution studies suggest that CEP152 is
under positive selection in the human lineage. This is
consistent with reports of positive selection for other char-
acterized human microcephaly genes, and it suggests that
these genes may play an important role in the rapid and
disproportionate increase in total brain size in primates
and especially in humans. By dividing the protein into
segments, we could detect selection signatures for speciﬁc
residues in the human gene. The individual sites ofCEP152
potentially under evolutionary selection do not include
either of the residues mutated in our human microcephaly
patients. This is not particularly surprising, because resi-
dues of the protein mutable to a loss-of-function pheno-
type could potentially include any functionally important
positions, whereas sites under positive selection are ex-
pected to be only a subset of functionally important sites
for which adaptive variation arose by chance and survived
to achieve ﬁxation. There were too few variable sites in the
gene among human sequences to measure selection across
human subpopulations. By inspection of Neandertal
genomic sequence reads submitted to GenBank, the
modern human amino acid residues are predicted at each
of the speciﬁc sites under potential selection.
CEP152 was originally identiﬁed as a component of
mammalian centrosomes through direct proteomic anal-
ysis.40,41 Other centrosomal or chromosomal organizing
proteins mutate to cause PM types 1, 3, 5, 6, and 7.
CEP152 is the likely mammalian ortholog of the Drosophila
gene asterless, which has been studied intensively for its
role in cell division and development.42,43 Mutations in as-
terless cause arrest of embryogenesis in the ﬂy, or else male
infertility, and the protein product of asterless was directly
localized to centrioles,42 consistent with our results for
CEP152 in human cells. Antisense knockdown of the puta-
tive CEP152 asterless ortholog in zebraﬁsh led to a curly-
tail phenotype typical of centriolar or ciliary defects.43 These
model-organismstudies support a role forCEP152 inmitosise American Journal of Human Genetics 87, 40–51, July 9, 2010 45
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Figure 4. Sequence Analysis of CEP152
(A) Multiple sequence alignment of
CEP152 in human and other vertebrates
in the region surrounding mutated residue
Q265. Themutation to proline is indicated
by a P above the human sequence.
(B) Domain structures of CEP152 predicted
by NCBI. Red arrows indicate the approxi-
mate location of mutations at residues 265
(Q-to-P in coiled-coil domainSMC_prok_B)
and987 (truncatingdomainSMC_prok_A).
(C) Coiled-coil domain predictions for
wild-type and p.Q265P mutant CEP152
for four bioinformatic tools.consistent with other known PM genes. Together, our ﬁnd-
ings strongly suggest that we have identiﬁed the causal
gene for microcephaly type MCPH4 in our three affected
patients. It remains to be seen whether CEP152 is also
mutated in other published families linked to this chromo-
somal region.
Although we could not document parental consan-
guinity in our families, strong founder effects have been
observed in Acadian francophonic populations. In other
studies, we used dense SNP genotyping together with
homozygosity analysis to map and identify causal muta-
tions in patients with congenital sideroblastic anemia
and cutis laxa type II in families from this region of eastern
Canada.44,45 The occurrence of a compound heterozygote
among our three patients was unanticipated but not
unusual. Such individuals presumably arise from a more
prevalent deleterious mutation, rising to moderately
increased frequency through an early founder effect,
combining with a second mutation arising more recentlyFigure 3. Sequences of Affected Patients Carrying Mutations in CEP152
The upper part of each panel shows wild-type amino acid sequence above, mutant amino a
panel shows four chromatogram traces; uppermost and lowermost are virtual forward and rev
ware from the consensus wild-type sequence, and inner traces are forward and reverse chro
sample. The two center tracks are mutation-detection calls by MutationSurveyor for forwa
green curve reach signiﬁcance according to the software calling algorithm. The red arrow
patient’s forward and reverse sequences.
(A) Homozygous mutation p.Q265P in CEP152 in patient 1669 with PM.
(B) Heterozygous mutation p.R987X in CEP152 in patient 1937 with PM.
The American Journal of Hand thus found only in the heterozy-
gous state. We similarly identiﬁed two
different mutations in the sacsin gene
(SACS [MIM 604490]) in two Mari-
time Canadian ataxia families, in
which one family was homozygous
and the other compound heterozy-
gous for the same mutation plus
a different second mutation.46
Our three patients studied showed
overall phenotypic similarity, in-
cluding severe microcephaly from
birth and absence of other dysmor-phic features. They shared a similar developmental
pattern, with mild delay in early motor development,
moderate cognitive impairment, difﬁcult behavior
patterns, but no other neurological abnormalities. This
clinical picture, as well as the ﬁndings on MRI scanning
of one patient, is consistent with the ﬁndings reported in
other children with autosomal-recessive PM.
According to the published mapping, the as-yet-uniden-
tiﬁed MCPH2 gene lies in a 9.7 Mbp region of chromo-
some 19q13. This region contains several interesting
candidates, including genes potentially involved in cell-
growth regulation (PDCD2L, WTIP, MAP4K1 [MIM
601983], MAP3K10 [MIM 600137], LTBP4 [MIM 604710],
CIC [MIM 612082]) or brain ciliary function (B9D2 [MIM
611951], putative ortholog of the mouse gene stumpy,
which has brain and renal phenotypes) and the gene
HAUS5, encoding a component of the multiprotein Aug-
min or HAUS complex, which is essential for centrosome
function in dividing cells.47–49cid sequence below. The lower part of each
erse traces, respectively, created by the soft-
matograms, respectively, from the patient
rd and reverse sequences; peaks above the
s points to the mutations in the affected
uman Genetics 87, 40–51, July 9, 2010 47
Figure 5. Expression of CEP152 in Embryonic Mouse Brains
RT-PCRwas performed on stage 12.5 or 14.5 embryonic brain RNA
with the use of primers designed to amplify across multiple splice
junctions of the mouse orthologous gene.With respect to PM, amajor outstanding question is why
mutations of the MCPH genes cause this phenotype and
not amore general developmental or syndromic condition.
Some centriolar and centrosomal proteins are implicated in
a variety of different human-disease syndromes.50 For
example, mutations in the SMC1A gene (MIM 300040),
whose product contains an SMC domain similar to
CEP152, can cause Cornelia de Lange syndrome (CdLS
[MIM 300590]).51 The phenotype of CdLS includes micro-
cephaly together with dysmorphologies. Mutations in the
gene encoding pericentrin2 (MIM 605925), another mitotic
gene, causemicrocephaly togetherwithdwarﬁsmandother
abnormalities.52 One possibility is that theMCPHgenes are
expressed speciﬁcally in developing brain cells. However,
this appears unlikely on the basis of centrosomal proteomic48 The American Journal of Human Genetics 87, 40–51, July 9, 2010studies carried out with cells of lymphoblastoid origin,41 as
well as reported expression patterns in BioGPS. Conceiv-
ably, there might be alternatively spliced protein isoforms
speciﬁc to embryonic brain cells, or cell type speciﬁc func-
tional protein domains. For the MCPH5 gene (ASPM),
however, there are 69 reported point or small indel muta-
tions scattered throughout the gene from residue 117 to
3353 out of 3477 (according to the HGMD Professional
database), suggesting that there is not a speciﬁc region of
the gene required uniquely in brain cells; moreover, the
gene is reportedly expressed in many tissues.37 There are
only small numbers of mutations reported for other
MCPH genes (MCPH1, CDKRAP, STIL, CENPJ), so this
hypothesis is perhaps more viable for those genes. In the
case of CEP152, we found a missense mutation early in
the gene and a termination codon removing approximately
the last thirdof the coding sequence; thus, these fall inquite
different regions of the protein’s primary sequence.
It appears most likely that the developing brain has
a special requirement for the functions of theMCPH genes.
The reasons for this are unknown, although cell division in
embryonic brains may be different than other cell divi-
sions during early development.53 There are probably addi-
tional PM loci to be found (besides the gene underlying
MCPH2), but probably not in large numbers. This is in
contrast to the case of more general intellectual disability,
in which the number of genes with potentially causal
alleles is rising rapidly as larger segments of the genome
are queried with the use of high-throughput sequencing
and other structural genomics technologies.54,55Figure 6. Functional Analysis of CEP152
Mutants
Human cells were transfected with vectors
expressing either wild-type or mutant
human CEP152 fused to GFP. In each
row, the left panel shows antibody stain-
ing to g-tubulin to mark centrosomes;
the center panel shows GFP ﬂuorescence;
the right panel shows merged g-tubulin
plus GFP plus Hoechst, with insert at
a higher magniﬁcation of centrosomes.
Top row: cells transfected with vector
alone (just GFP); middle row, cells trans-
fected with wild-type CEP152-GFP fusion;
bottom row, cells transfected with
p.R987X mutant CEP152-GFP fusion.
Scale bar represents 5 mm.
Figure 7. Selection Analysis of CEP152 in
Vertebrates
(A) Phylogenetic tree and u ratios for
CEP152 coding sequences. For all
branches, the u ratio is set free to vary.
The maximum-likelihood estimate of u is
shown along each branch.
(B) Log likelihood values and parameter
estimates under different branch models.
The parameters in each model are the 16
branch lengths of the tree (number of
nucleotide substitutions per codon), the
transition/ transversion rate ratio k, and
the u ratio(s). Estimates of branch lengths
and k are not shown. To test whether the
human ratio is signiﬁcantly different
from the others, we focused speciﬁcally
on comparisons among the human (H),
primates (P), and other (O) lineages. uH,
uP, and u0 are thus the dN/dS ratios for
branches H, P, and all other branches,
respectively. Signiﬁcant model compar-
ison: B (H0) and D (H1): p ¼ 1.23 3 102,
ﬁxed-ratio models (H0) and free-ratio
(H1): p < 1010.
(C) Sites ofCEP152underpotential positive
selection in humans. The log likelihood
ratio test supports the branch-site model
of positive selection with p ¼ 2.62 3 102
for the general test. P(u > 1) are the poste-
rior probabilities of speciﬁc potential sites
under positive selection in the human
lineage.Apparently isolated PM is a more speciﬁc phenotype than
intellectual disability, with fewer potentially causal genes
or mutations.52,56–58Supplemental Data
Supplemental Data include seven ﬁgures and ﬁve tables and can be
found with this article online at http://www.cell.com/AJHG.Acknowledgments
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BioGPS gene expression portal, http://biogps.gnf.org/
#goto¼welcome
COILS server, http://www.ch.embnet.org/software/COILS_form.
html
HGMD public database, http://www.hgmd.cf.ac.uk/ac/index.php
HGNC gene nomenclature, http://www.genenames.org/index.
htmluman Genetics 87, 40–51, July 9, 2010 49
Marcoil server, http://www.isrec.isb-sib.ch/webmarcoil/
webmarcoilC1.html
Online Mendelian Inheritance in Man (OMIM), http://www.ncbi.
nlm.nih.gov/omim
Paircoil2 server, http://groups.csail.mit.edu/cb/paircoil2/
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